{"entity":{"type":"insider","cik":"0001939159","url":"/insider/0001939159","json_url":"/insider/0001939159.json","name":"Bernards Rene","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":7,"n_filings":5,"first":"2022-11-15","last":"2023-10-05","span_basis":"filed_date"},"name_variants":[{"name":"Bernards Rene","source":"filing","n_filings":5,"first_seen":"2022-11-15","last_seen":"2023-10-05"}],"transactions":[{"id":9290242,"accession":"0001493152-23-036424","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001493152-23-036424","line_url":"/filing/0001493152-23-036424#line-2","is_derivative":false,"issuer_cik":"0001335105","issuer_name":"LIXTE BIOTECHNOLOGY HOLDINGS, INC.","issuer_ticker":"LIXT","issuer_name_source":null,"issuer_url":"/issuer/0001335105","owner_cik":"0001939159","owner_name":"Bernards Rene","owner_display_name":"Bernards Rene","owner_url":"/insider/0001939159","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5527.0,"shares_display":"5,527","price_per_share":2.51,"price_display":"2.51","price_state":"stated","total_value":13872.77,"total_display":"13,872.77","total_whole":"13,873","shares_owned_after":25000.0,"shares_owned_after_display":"25,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-03","filed_date":"2023-10-05","scope":"insider"},{"id":7943003,"accession":"0001493152-23-035712","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001493152-23-035712","line_url":"/filing/0001493152-23-035712#line-2","is_derivative":false,"issuer_cik":"0001335105","issuer_name":"LIXTE BIOTECHNOLOGY HOLDINGS, INC.","issuer_ticker":"LIXT","issuer_name_source":null,"issuer_url":"/issuer/0001335105","owner_cik":"0001939159","owner_name":"Bernards Rene","owner_display_name":"Bernards Rene","owner_url":"/insider/0001939159","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5527.0,"shares_display":"5,527","price_per_share":2.51,"price_display":"2.51","price_state":"stated","total_value":13872.77,"total_display":"13,872.77","total_whole":"13,873","shares_owned_after":null,"shares_owned_after_display":null,"ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-03","filed_date":"2023-10-04","scope":"insider"},{"id":9290243,"accession":"0001493152-23-036424","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-23-036424","line_url":"/filing/0001493152-23-036424#line-1","is_derivative":false,"issuer_cik":"0001335105","issuer_name":"LIXTE BIOTECHNOLOGY HOLDINGS, INC.","issuer_ticker":"LIXT","issuer_name_source":null,"issuer_url":"/issuer/0001335105","owner_cik":"0001939159","owner_name":"Bernards Rene","owner_display_name":"Bernards Rene","owner_url":"/insider/0001939159","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4473.0,"shares_display":"4,473","price_per_share":2.29,"price_display":"2.29","price_state":"stated","total_value":10243.17,"total_display":"10,243.17","total_whole":"10,243","shares_owned_after":19473.0,"shares_owned_after_display":"19,473","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-02","filed_date":"2023-10-05","scope":"insider"},{"id":7943001,"accession":"0001493152-23-035712","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-23-035712","line_url":"/filing/0001493152-23-035712#line-1","is_derivative":false,"issuer_cik":"0001335105","issuer_name":"LIXTE BIOTECHNOLOGY HOLDINGS, INC.","issuer_ticker":"LIXT","issuer_name_source":null,"issuer_url":"/issuer/0001335105","owner_cik":"0001939159","owner_name":"Bernards Rene","owner_display_name":"Bernards Rene","owner_url":"/insider/0001939159","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4473.0,"shares_display":"4,473","price_per_share":2.29,"price_display":"2.29","price_state":"stated","total_value":10243.17,"total_display":"10,243.17","total_whole":"10,243","shares_owned_after":null,"shares_owned_after_display":null,"ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-02","filed_date":"2023-10-04","scope":"insider"},{"id":6514397,"accession":"0001493152-22-035794","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-22-035794","line_url":"/filing/0001493152-22-035794#line-1","is_derivative":false,"issuer_cik":"0001335105","issuer_name":"LIXTE BIOTECHNOLOGY HOLDINGS, INC.","issuer_ticker":"LIXT","issuer_name_source":null,"issuer_url":"/issuer/0001335105","owner_cik":"0001939159","owner_name":"Bernards Rene","owner_display_name":"Bernards Rene","owner_url":"/insider/0001939159","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":0.51,"price_display":"0.51","price_state":"stated","total_value":7650.0,"total_display":"7,650.00","total_whole":"7,650","shares_owned_after":150000.0,"shares_owned_after_display":"150,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-15","filed_date":"2022-12-16","scope":"insider"},{"id":6950184,"accession":"0001493152-22-035280","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-22-035280","line_url":"/filing/0001493152-22-035280#line-1","is_derivative":false,"issuer_cik":"0001335105","issuer_name":"LIXTE BIOTECHNOLOGY HOLDINGS, INC.","issuer_ticker":"LIXT","issuer_name_source":null,"issuer_url":"/issuer/0001335105","owner_cik":"0001939159","owner_name":"Bernards Rene","owner_display_name":"Bernards Rene","owner_url":"/insider/0001939159","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.61,"price_display":"0.61","price_state":"stated","total_value":6100.0,"total_display":"6,100.00","total_whole":"6,100","shares_owned_after":135000.0,"shares_owned_after_display":"135,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-12","filed_date":"2022-12-13","scope":"insider"},{"id":6347153,"accession":"0001493152-22-032564","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-22-032564","line_url":"/filing/0001493152-22-032564#line-1","is_derivative":false,"issuer_cik":"0001335105","issuer_name":"LIXTE BIOTECHNOLOGY HOLDINGS, INC.","issuer_ticker":"LIXT","issuer_name_source":null,"issuer_url":"/issuer/0001335105","owner_cik":"0001939159","owner_name":"Bernards Rene","owner_display_name":"Bernards Rene","owner_url":"/insider/0001939159","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":52500.0,"shares_display":"52,500","price_per_share":0.53,"price_display":"0.53","price_state":"stated","total_value":27825.0,"total_display":"27,825.00","total_whole":"27,825","shares_owned_after":125000.0,"shares_owned_after_display":"125,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-14","filed_date":"2022-11-15","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":7,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":7,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":7},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001335105","name":"LIXTE BIOTECHNOLOGY HOLDINGS, INC.","url":"/issuer/0001335105","role":"Director","n_filings":5,"first_seen":"2022-11-15","last_seen":"2023-10-05"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001939159","retrieved_at":"2026-08-26T20:29:52+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}